Trials / Sponsors / Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Le Dravet Syndrome, Lennox Gastaut Syndrome | Phase 1 | 2018-01-19 |
| Completed | A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy Lennox Gastaut Syndrome | Phase 3 | 2017-11-27 |
| Terminated | A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Drave Dravet Syndrome | Phase 3 | 2017-07-12 |
| Completed | A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safet Dravet Syndrome | Phase 3 | 2017-01-27 |
| Completed | An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral So Dravet Syndrome | Phase 3 | 2016-06-08 |
| Completed | A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome Dravet Syndrome, Seizure Disorder | Phase 3 | 2016-01-15 |